Who is Tosoh India?

Tosoh India Pvt. Ltd., based in Mumbai, the commercial capital of India, is a subsidiary of Tosoh Corporation. Headquartered in Tokyo, Japan, Tosoh Corporation is a conglomerate of diversified world class companies operating across the globe. Founded in 1935, Tosoh has emerged as a global giant in its various markets with a multiethnic workforce of over 11,000 people across over 100 companies.

Tosoh is a globally respected name in the chemical and specialty material industry and manufactures a wide array of basic and innovative specialty chemicals that serve a multitude of industry segments. Tosoh has also pioneered sophisticated bioscience systems that are used in the clinical diagnostics domain as well as in research and bioscience laboratories world over.

Tosoh's Bioscience Division, operating under the globally unified brand Tosoh Bioscience, has emerged as a technology leader in the field of automated immunoassay analyzers, HPLC based automated systems for diabetes and thalassemia screening as well as molecular diagnostics. And harnessing deep scientific understanding, research and manufacturing ability of HPLC resins as well as columns has made Tosoh Bioscience a forerunner in the industry.

Tosoh Corporation’s entry in the Indian subcontinent transpired with the April 2015 acquisition of Lilac Medicare (P) Ltd., a leading Indian clinical diagnostic company. Renamed Tosoh India Pvt. Ltd. (formerly Lilac Medicare (P) Ltd.), the company has not only retained Lilac’s dominating presence in the microwell Elisa & Chemiluminescence based semi-automated immunoassay business but has also reinforced its presence in the clinical diagnostic market through Tosoh’s pioneering range of advanced Japanese technology based automated immunoassay platforms and HPLC based systems for diabetes and thalassemia screening.

With a proven reputation, innovative path breaking technology, high quality assay results and a deep commitment towards addressing customer needs, Tosoh India Pvt. Ltd. is poised for redefining the future of clinical diagnostics not only in India but also in the neighboring countries of Nepal, Bhutan, Bangladesh and Sri Lanka.